GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:26602794
| Citation |
Plainvert, C, Martin, C, Loubinoux, J, Touak, G, Dmytruk, N, Collobert, G, Fouet, A, Ploy, MC and Poyart, C Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin. Med Mal Infect 45:470-4 |
|---|---|
| Abstract |
Emm1-type group A Streptococcus (GAS), or Streptococcus pyogenes, is mostly responsible for invasive infections such as necrotizing fasciitis (NF) and streptococcal toxic shock syndrome (STSS). The recommended treatment of severe invasive GAS infections is a combination of clindamycin and penicillin. Until 2012, almost all emm1 isolates were susceptible to clindamycin. |
| Links |
PubMed Online version:10.1016/j.medmal.2015.10.008 |
| Keywords |
|
Significance
Annotations
| Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0008800: beta-lactamase activity |
ECO:0000314: |
F |
Table 1 indicates that Group A Streptococcus was isolated from a variety of sources with many different clinical symptoms and backgrounds, yet they resulted in the same gene profile. |
complete | ||||
Notes
See also
References
See Help:References for how to manage references in GONUTS.
